Inflammation and degeneration in multiple sclerosis W. BrückC. Stadelmann Original Paper Pages: s265 - s267
The transition from relapsing-remitting MS to irreversible disability: clinical evaluation M. TrojanoD. PaolicelliS. Cataldo Original Paper Pages: s268 - s270
Biological markers of the inflammatory phase of multiple sclerosis A. UccelliE. PedemonteG. Mancardi Original Paper Pages: s271 - s274
MRI aspects of the “inflammatory phase” of multiple sclerosis M. FilippiM. A. Rocca Original Paper Pages: s275 - s278
Biological indicators of the neurodegenerative phase of multiple sclerosis M. Zaffaroni Original Paper Pages: s279 - s282
Imaging neuronal and axonal degeneration in multiple sclerosis N. De StefanoL. GuidiA. Federico Original Paper Pages: s283 - s286
Physiopathology of multiple sclerosis A. ViscontiS. SantucciM. Salvetti Original Paper Pages: s287 - s290
From inflammation to degeneration: the lessons of clinical trials G. Comi Original Paper Pages: s295 - s297
Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis F. BagnatoV. DurastantiE. Millefiorini Original Paper Pages: s301 - s304